GGrantIndex
← Search

DEVELOPMENT & MANUFACTURE OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF SUBSTANCE ABUSE DISORDERS. NIDA REF. NO. N01DA-16-8926; POP: 09/18/2016 - 09/17/2021.

$93,608N01FY2019DANIH

Murty Pharmaceuticals, Inc., Lexington KY

Investigators

Abstract

To carry out the development and manufacture of pharmaceutical preparations to be used in the medications development program of the National Institute on Drug Abuse (NIDA) for treating substance use disorders.

View original record on NIH RePORTER →